About Germitec
Germitec is a company based in Bordeaux (France) founded in 2005 by Clement Deshays. Germitec has raised $41.59 million across 2 funding rounds from investors including Eurazeo, Kurma Partners and Financiere Arbevel. Germitec offers products and services including Chronos, Antigermix, and Yuvee. Germitec operates in a competitive market with competitors including Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others.
- Headquarter Bordeaux, France
- Founders Clement Deshays
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.59 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series B
Feb 12, 2025
-
Investors
Eurazeo
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Germitec
Germitec offers a comprehensive portfolio of products and services, including Chronos, Antigermix, and Yuvee.
Offers 90-second UV-C high-level disinfection for ultrasound probes.
Provides UV-C disinfection for long endocavitary probes in three minutes.
Delivers UV-C based solutions to kill pathogens on medical devices.
People of Germitec
Unlock access to complete
Unlock access to complete
Funding Insights of Germitec
Germitec has successfully raised a total of $41.59M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Germitec
Germitec has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Kurma Partners and Financiere Arbevel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Biotech startups are funded through venture capital in life sciences.
|
Locked | Locked | Locked | |
|
Private equity investments are made in companies across diverse sectors.
|
Locked | Locked | Locked |
Investor details for Germitec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Germitec
Investment portfolio details for Germitec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Germitec
Detailed financials for Germitec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Germitec Comparisons
Peer comparison for Germitec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Germitec
Germitec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| Locked | Locked | Locked |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| Locked | Locked | Locked |
UV-C disinfection devices for hospital infection control are developed.
|
|
| Locked | Locked | Locked |
Portable ultrasound systems are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
Deep learning-based imaging diagnostics for heart diseases are developed.
|
Detailed competitors of Germitec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Germitec
Complete news archive for Germitec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Germitec
Germitec was founded in 2005 and raised its 1st funding round 17 years after it was founded.
Germitec is headquartered in Bordeaux, France.
Clement Deshays is the current CEO of Germitec. They have also founded this company.
Germitec is a funded company, having raised a total of $41.59M across 2 funding rounds to date.
Germitec was founded in 2005 in Bordeaux, France, and operates in the medical device sector. UV-C light-based systems for high-level disinfection of endocavitary and external ultrasound probes are developed and supplied. Pathogens including bacteria, fungi, viruses, mycobacteria, and spores are targeted by the technology. Workflow optimization and traceability features are incorporated into the systems. A chemical-free method is employed to support healthcare operations across Europe and beyond.
Germitec's top competitors include Butterfly Network, Exo and R-Zero.
Germitec offers Chronos, Antigermix, and Yuvee.
Germitec has 7 investors. Key investors include Eurazeo, Kurma Partners, Financiere Arbevel, Turenne Groupe, and Sham.